Clinical trials are meant to determine whether devices, medications, or other developments in the medical field are safe for public use. These developments are at the cutting edge of the field, yet frequently, the trials to test their safety don’t incorporate the latest technologies (such as mobility).
There are reasons that companies have been leery of implementing mobile technologies in mobile trials: they’re concerned about regulatory issues, patient adherence, and cost. However, with the adoption of best practices, firms should no longer be concerned about using mobile technologies during regulatory trials.
Clinical trials are long, costly, and generally a huge undertaking for companies. Mobile devices can change that – they enable patients to participate remotely, saving money and time. That being said, mobile devices present some risks. Those risks can be mitigated, though. Read on to learn the risks of using mobile devices during clinical trials and how to mitigate them.